Wiley Matthew T.

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
4
Insider Sells Sum
$6,562.40

Insider Activity of Wiley Matthew T.

According to the SEC Form 4 filings, Wiley Matthew T., being in a position of

  1. Chief Commercial Officer at BioXcel Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 7739 shares for $6,562,
    over all time since 2024-04-04, has bought 0 shares, and sold 7739 shares for $6,562.

The largest sale of all time was on 2024-10-03 and amounted to 6272 shares of BioXcel Therapeutics, Inc. for $3,450.

Biography of Wiley Matthew T.

No biography is available at this moment.

2024-10-03SaleBioXcel Therapeutics, Inc.
BTAI
Chief Commercial Officer
6,272
0.0158%
$0.55$3,450-1.4%
2024-09-16SaleBioXcel Therapeutics, Inc.
BTAI
Chief Commercial Officer
215
0.0006%
$0.69$149-13.25%
2024-06-17SaleBioXcel Therapeutics, Inc.
BTAI
Chief Commercial Officer
244
0.0006%
$1.26$308-53.95%
2024-04-04SaleBioXcel Therapeutics, Inc.
BTAI
CHIEF COMMERCIAL OFFICER
1,008
0.0029%
$2.64$2,656-73.24%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.